Nobuyuki Horita
Nobuyuki Horita publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Chronic Obstructive Pulmonary Disease (COPD) Research, Cancer Immunotherapy and Biomarkers and Lung Cancer Treatments and Mutations.
- World rank
- #123,324 of 7,710,434 ranked researchers
- Rank in Japan
- #808 of 383,136
- Works
- 372
- Citations
- 92k
- Citations per work
- 246.2
What does Nobuyuki Horita research?
Nobuyuki Horita's work is mostly in Medicine (52%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences19452.1%
- Medicine19452.1%
- Everything else17847.9%
- 1Pulmonary and Respiratory Medicine19% of their works
- 2Oncology12% of their works
- 3Epidemiology11% of their works
- 4Physiology4% of their works
- 5Infectious Diseases4% of their works
- 6Surgery3% of their works
Research topics
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pneumonia and Respiratory Infections
- Lung Cancer Diagnosis and Treatment
- Asthma and respiratory diseases
Which keywords describe Nobuyuki Horita's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, Epidemiology, COPD, spirometry, Immune Checkpoint Blockade and PD-1 and PD-L1.
- Asthma
- Lung Cancer
- Pneumococcal Conjugate Vaccine
- Small-Cell Lung Cancer
- Genomic Profiles
- EGFR Mutations
- PD-1 and PD-L1
- spirometry
- Epidemiology
- Targeted Therapy
- Clinical Trials
- Chemotherapy
- COPD
- Immune Checkpoint Blockade
- ALK Inhibitors
- Fibrosis
- Idiopathic Pulmonary Fibrosis
- Community-Acquired Pneumonia
- CT Screening
- Allergic Diseases
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Clinical Trials642 topics
- Targeted Therapy642 topics
- Chemotherapy572 topics
- Epidemiology532 topics
- COPD401 topic
- spirometry401 topic
- Immune Checkpoint Blockade391 topic
- PD-1 and PD-L1391 topic
- ALK Inhibitors341 topic
- EGFR Mutations341 topic
- Fibrosis301 topic
- Genomic Profiles301 topic
- Idiopathic Pulmonary Fibrosis301 topic
- Small-Cell Lung Cancer301 topic
- Community-Acquired Pneumonia291 topic
- Pneumococcal Conjugate Vaccine291 topic
- CT Screening271 topic
- Lung Cancer271 topic
- Allergic Diseases241 topic
- Asthma241 topic
Where does Nobuyuki Horita work?
Nobuyuki Horita's main affiliation in the publication record is Yokohama City University, Japan.
How many publications and citations does Nobuyuki Horita have?
OpenAlex counts 372 works and 91,593 citations for Nobuyuki Horita, an h-index of 67, ranking #123,324 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nobuyuki Horita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.